false
0001069394
A0
0001069394
2025-03-31
2025-03-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (date of earliest event reported): March 31, 2025
FLEXIBLE
SOLUTIONS INTERNATIONAL INC.
(Exact
name of Registrant as specified in its charter)
Alberta |
|
001-31540 |
|
71-1630889 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File No.) |
|
(Employer
Identification
No.) |
6001
54 Ave.
Taber,
Alberta, Canada T1G 1X4
(Address
of principal executive offices, including Zip Code)
Registrant’s
telephone number, including area code: (250) 477-9969
N/A
(Former
name or former address if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol |
|
Name
of exchange on which registered |
Common
Stock |
|
FSI |
|
NYSE
American |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§204.12b-2 of this chapter.
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
8.01 Other Events
On
March 31, 2025, the Company issued a press release announcing its financial results for the year ended December 31, 2024.
On
April 1, 2025 the Company held a conference call to discuss its financial results for the year ended December 31, 2024, as well as other
information regarding the Company.
Item
9.01 Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
April 1, 2025 |
FLEXIBLE
SOLUTIONS INTERNATIONAL INC. |
|
|
|
|
By: |
/s/
Daniel B. O’Brien |
|
|
Daniel
B. O’Brien, President and Chief Executive Officer |
Flexible
8-K Item 8.01 Yr End Financial Results & Speech 4-1-25
EXHIBIT
99.1

NEWS
RELEASE |
March
31, 2025 |
FSI
ANNOUNCES FULL YEAR, 2024 FINANCIAL RESULTS
A
Conference call is scheduled for Tuesday April 1st, 2025, 11:00am Eastern Time
See
dial in number below
TABER,
ALBERTA, March 31, 2025 – FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of
biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry.
Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. In addition,
FSI is increasing its presense in the food and nutrition supplement manufacturing markets. Today the Company announces financial results
for full year ended December 31, 2024.
Mr.
Daniel B. O’Brien, CEO, states, “2024 was a significant improvement over 2023. Net income was up and non-GAAP cash flow improved
even more. Of particular note is the assessment of a temporary loss of $385 thousand related to our sale of units in the Florida LLC
which reduced net income by 3 cents even though the full term of the sale will result in a large profit.”
Mr.
O’Brien continues, “During 2024, we progressed toward potential purchase orders that could increase our revenue by Q4 2025
and could increase our 2026 revenue significantly. We have also taken concrete steps to limit the effects of tariffs on our international
sales, which we hope will generate growth in the next two years and we increased our efforts to recover the rebates of previously paid
tariffs that are due to us.”
|
● |
Sales
for the Full Year were $38,234,860 compared to sales of $38,324,806 in the corresponding period a year ago. |
|
|
|
|
● |
Full
Year, 2024 net income was $3,038,529 or $0.24 per share, compared to a net income of $2,775,864, or $0.22 per share, in Full Year,
2023. |
|
|
|
|
● |
Basic
weighted average shares used in computing earnings per share amounts were 12,454,957 and 12,434,886 for full year, 2024 and full
year, 2023 respectively. |
|
|
|
|
● |
2024
Non-GAAP operating cash flow: The Company shows 12 months operating cash flow of $7,082,952, or $0.57 per share. This compares
with operating cash flow of $4,604,320, or $0.37 per share, in the corresponding 12 months of 2023 (see the table that follows for
details of these calculations). |
The
NanoChem division and ENP subsidiary continue to be the dominant sources of revenue and cash flow for the Company. New opportunities
continue to unfold in detergent, water treatment, oil field extraction, turf, ornamental and agricultural use to further increase sales
in these divisions. More recently, opportunities in the food and nutrition supplement manufacturing markets have emerged.
Conference
call
Due
to business travel obligations a conference call has been scheduled for 11:00 am Eastern Time, 8:00 am Pacific Time, on
Tuesday April 1st, 2025. CEO, Dan O’Brien will be presenting and answering questions on the conference call. To participate
in this call please dial 1-888-999-5318 (or 1-848-280-6460) just prior to the scheduled call time. To join the call participants will
be requested to give their name and company affiliation. The conference ID: SOLUTIONS and/or call title Flexible
Solutions International - Full Year 2024 Financials may be requested
Note:
The above information and following table contain supplemental information regarding income and cash flow from operations for the period
ended December 31, 2024. Adjustments to exclude depreciation, stock option expenses and one time charges are given. This financial information
is a Non-GAAP financial measure as defined by SEC regulation G. The GAAP financial measure most directly comparable is net income.
| |
12 months ended December 31 | |
| |
2024 | | |
2023 | |
Revenue | |
$ | 38,234,860 | | |
$ | 38,324,806 | |
Income (loss) before income tax – GAAP | |
$ | 4,952,800 | | |
$ | 3,623,250 | |
Provision for Income tax(recovery) – net - GAAP | |
$ | 851,211 | | |
$ | (132,735 | ) |
Net income (loss) - GAAP | |
$ | 3,038,529 | | |
$ | 2,775,864 | |
Net income (loss) per common share – basic. – GAAP | |
$ | 0.24 | | |
$ | 0.22 | |
12 month weighted average shares used in computing per share amounts – basic.- GAAP | |
| 12,454,957 | | |
| 12,434,886 | |
| |
12 month Operating Cash Flow
Ended December 31
| |
Operating Cash Flow (12 months). NON-GAAP | |
$ | 7,082,952 | a,b,c | |
$ | 4,604,320 | a,b,c |
Operating Cash Flow per share excluding non-operating items and items not related to current operations (12 months) – basic. -NON-GAAP | |
$ | 0.57 | a,b,c | |
$ | 0.37 | a,b,c |
Non-cash Adjustments (12 month) -GAAP | |
| $ 2,630,606 | d | |
| $ 2,081,399 | d |
Shares (12 month basic weighted average) used in computing per share amounts – basic -GAAP | |
| 12,454,957 | | |
| 12,434,886 | |
Notes:
certain items not related to “operations” of the Company’s net income are listed below.
a)
Non-GAAP – Flexible Solutions International owns 65% of ENP and 80% of 317 Mendota. Therefore Operating Cash Flow is adjusted
by the pre-tax Net income or loss of the non-controlling interest (minority interest) in both entities. A pretax minority interest number
now appears in the financials for full year 2023 and future years.
b)
Non-GAAP – amounts exclude certain cash and non-cash items: Depreciation and Stock compensation expense (2024 = $2,630,606,
2023 = $2,081,399), Interest expense (2024 = $610,265, 2023 = $498,666), Interest income (2024 = $196,464, 2023 = $113,809), Gain on
investment (2024 = $245,631, 2023 = 505,065), Loss on sale of investment (2024 = $353,076, 2023 = N/A), Loss on lease termination (2024
= $41,350, 2023 = N/A) Deferred income tax (expense) benefit (2024 = $(146,767), 2023 = $250,917), Current Income tax expense (2024 =
$704,444, 2023 = $118,182), and pretax Net income attributable to non-controlling interests (2024 = $1,063,060, 2023 = $980,121) are
removed to arrive at Operating Cash Flow. Although included in operating expenses these expenditures were not related to operations of
FSI. *See the financial statements for all adjustments.
c)
The revenue and gain from the investment in the private Florida LLC announced in January 2019 are not treated as revenue or profit
from operations by Flexible Solutions. The profit is treated as investment income and therefore occurs below Operating income in the
Statement of Operations. As a result, the gains from all investments (2024 – 245,631, 2023 = $505,065), including those from the
Florida LLC, are removed from the calculation to arrive at Operating Cash Flow.
d)
Non-GAAP – amounts represent depreciation and stock compensation expense.
Safe
Harbor Provision
The
Private Securities Litigation Reform Act of 1995 provides a “Safe Harbor” for forward-looking statements. Certain of the
statements contained herein, which are not historical facts, are forward looking statement with respect to events, the occurrence of
which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various
factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s
reports filed with the Securities and Exchange Commission.
Flexible
Solutions International
6001
54th Ave, Taber, Alberta, CANADA T1G 1X4
Company
Contacts
|
Jason
Bloom |
|
Toll
Free: 800 661 3560 |
|
Fax:
403 223 2905 |
|
E-mail:
info@flexiblesolutions.com |
If
you have received this news release by mistake or if you would like to be removed from our update list please reply to: info@flexiblesolutions.com
To
find out more information about Flexible Solutions and our products, please visit www.flexiblesolutions.com.
Flexible
Press Release re Yr End Financial Results 4-1-25
EXHIBIT
99.2
FY
2024 speech
Good
morning. I’m Dan O’Brien, CEO of Flexible Solutions.
Safe
Harbor provision:
The
Private Securities Litigation Reform Act of 1995 provides a “Safe Harbor” for forward-looking statements. Certain of the
statements contained herein, which are not historical facts, are forward looking statements with respect to events, the occurrence of
which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various
factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s
reports filed with the Securities and Exchange Commission.
Welcome
to the FSI conference call for FY 2024.
I
would like to discuss our Company condition and our product lines first along with what we think might occur in the first half of 2025.
A substantial portion of this speech will address the recent food grade product contract and our actions to limit tariffs on international
sales. I will comment on our financials in the second part of the speech.
NanoChem
division: NCS represents approximately 70% of FSI’s revenue. This division makes thermal poly-aspartic acid, called TPA for
short, a biodegradable polymer with many valuable uses. NCS also manufactures SUN 27™ and N Savr 30™ which are used to reduce
nitrogen fertilizer loss from soil. In 2022, NCS started food grade toll operations.
TPA
is used in agriculture to significantly increase crop yield. It acts by slowing crystal growth between fertilizer ions and other
ions in the soil resulting in the fertilizer remaining available longer for the plants to use.
TPA
is a biodegradable way of treating oilfield water to prevent scale. Preventing scale keeps oil recovery pipes from clogging.
TPA
is also sold as a biodegradable ingredient in cleaning products, and as a water treatment chemical.
In
our food division, a special version of TPA is sold as a stability aid.
SUN
27™ and N Savr 30™ are nitrogen conservation products. Nitrogen is a critical fertilizer that can be lost through bacterial
breakdown, evaporation and soil runoff.
SUN
27™ is used to conserve nitrogen from attack by soil bacterial enzymes that cause evaporation while N Savr 30™ is effective
at reducing nitrogen loss from leaching.
Food
products: Our IL plant is food grade qualified and we have received our FDA and SQF certifications. We have commercialized one food
product based on polyaspartates that was developed fully in house.
In
January, we announced a significant food grade contract. In order to achieve the objectives of that contract, there are certain steps
that must first be completed. For example, we need to install new, specialized equipment capable of manufacturing the product.
In
addition, we need to install a new “clean room” because our current clean rooms are not suitable for the processes.
There
will be CAPEX associated with our efforts to earn this business as our food grade improvements over the last 2 years did not anticipate
this new product category. We estimate additional CAPEX of approximately $4 million for equipment and plant improvements combined. We
have substantial cash on hand in our US subsidiaries and access to a mostly unused LOC. There will be no equity financing needed.
CAPEX
involving equipment and improvements requires lead time for delivery and installation time prior to testing leading, hopefully, to purchase
orders for production. These lead times are being reduced as much as we can control and our estimate of the earliest that production
could begin is Q4. After we are satisfied that we can manufacture the product at scale, and assuming that we can still meet our customer’s
pricing expectations, we then hope to begin receiving purchase orders. As such, we believe that revenue could begin in Q4 and could reach
significant levels by the start of 2026.
Managing
to earn these future purchase orders and hopefully growing them to the estimated maximum revenue of $30 million per year is the critical
goal of the next 4 - 6 quarters. We hope to execute this to the customers’ absolute satisfaction and obtain orders before taking
on additional major projects.
As
part of the clean room and equipment expansion program, we expect to be able to quickly increase capacity by adding duplicate equipment.
In
addition, we have extra capacity in certain food product categories available and have done R&D toward significant business in several
products. Therefore, we could accept new business from these potential customers provided it does not interfere with our primary efforts.
ENP
Division: ENP represents most of our other revenue. ENP is focused on sales into the greenhouse, turf and golf markets. NCS sells
into row crop agriculture. The mild growth we predicted for the second half of 2024 occurred and we expect this trend to continue in
2025 with the growth occurring in the second half of 2025.
The
Florida LLC investment: The LLC was profitable for the 2024 year but sales to them were lower. The Company is focused on international
agriculture sales into multiple countries. Its management has advised us that they estimate a return to growth in 2025 which should translate
into increased revenue for FSI.
In
third quarter 2024, we sold this asset for $2 million in cash and $800,000 per year for 5 years, a total of $6 million. Our total purchase
price was $3.5 million. The LLC has retained us as an exclusive supplier for 5 years and we hope to extend the contract even longer by
being better than any competitors. We also retain our rights to share in the LLC profits during the payout period according to our remaining
ownership ratio.
The
structure of the sale resulted in an accounting loss of $385 thousand applied to 2024. As we begin receiving the deferred payments in
Q4 2025 through 2029, the loss will change to a gain. The temporary accounting treatment reduced earnings for 2024 by 3 cents per share.
Agricultural
products in the US are selling reasonably well but crop prices are still not increasing at the rate of inflation. Growers are facing
a conflict between rising costs and low crop prices. We feel that because our products help increase yield in some cases while reducing
costs in others that we may be successful in growing sales in 2025. We should mention that counter-tariffs by countries affected by the
US tariff policies may affect US grower profits and morale, therefore, their willingness to buy inputs. As a result, predictions are
very difficult.
Food
division sales are projected to grow in 2025 depending on how early production of the new major product might begin and any increased
uptake for our existing polymer food product.
Tariffs:
Since 2019, several of our raw materials imported from China have included a 25% tariff. International customers are not charged
the tariffs because we have applied for the export rebates available to recover the tariffs. The tariffs are affecting our cost of goods,
our cash flow and our profits negatively. Rebates are extremely difficult to obtain even though we are entitled to them. We submitted
our initial applications more than 5 years ago. The total dollar amount due to us is well in excess of $1 MM and grows each quarter.
In December 2024, we hired a specialist consulting group to help us obtain the rebates due to us. It had become obvious that the rebate
department of the US government was not willing to work with us directly. The consultants will take 10% of what is recovered.
Panama
factory for international sales: We are pleased to disclose our long-term response to US tariff policy. We are developing a duplicate
facility in the Country of Panama that will be capable of producing nearly all the agriculture and polymer products we sell to international
customers. We estimate that first production from this factory will begin in Q3 2025. Equipment is being shipped now and installation
will begin soon. CAPEX and operational costs to develop the new plant have been funded by cash flow and retained earnings. There will
be no need for debt or equity financing.
Once
operational, nearly all of our products for international sale will be made in Panama using raw materials sourced without the US tariffs.
We will no longer have to pay tariffs on materials for US made products destined for export and then spend years getting the rebates.
There will also be advantages related to shipping; the new plant is 30 minutes from a port. Inbound raw materials and outbound finished
goods will not have to be shipped across the US, to and from IL, for our international customers. Delivery times will be shortened by
many days.
Reducing
shipping times and removing our exposure to tariffs on international sales could allow us to increase sales to existing customers and
obtain new customers over the next 2 years.
Another
important point is that, moving agriculture and polymer production to Panama, frees space at the IL plant so that food grade production
can be optimized and expanded substantially as customers are found.
Shipping
and Inventory: Shipping prices are stable but higher than prior to covid. Shipping times are reasonable on the routes we use. None
of our products or raw materials ship through the Red Sea area. We ordered extra inventory to position on US soil ahead of January 20
2025. During the transition of agriculture and polymer production from IL to Panama, we may still need to bring some raw materials to
the US. We will have to pay tariffs and then apply for rebates on those materials.
Raw
material prices are stable but increasing slowly with inflation. Passing price increases, even small inflation related ones, along to
customers always takes time. We negotiate price rises whenever we can.
GLP-1
drug production line: The drug compounding industry is a logical, long-term progression for FSI so, when a production line for injectable
drugs became available at an extremely low price, we bought it. We intend to de-risk our possible entry by securing sales prior to further
expenditure and by looking for partners. We will proceed only when we have reduced risk sufficiently.
FSI
has progressed from good manufacturing practice to food grade and SQF certification and production over the last 3 years. We have developed
the skills to build and operate clean room environments as part of our food/nutrition division and are comfortable that our skills are
transferable to drug operations.
Our
careful entry into this area has allowed us to avoid the recent price drops and extra availability of GLP1 drugs. We remain extremely
positive about this opportunity but finding advance orders and a partner is critical to success and may take significant time.
Highlights
of the financial results:
We
maintained our revenue in 2024, with better profits than in 2023. There was weakness in sales to the FL LLC in Q4 and our existing food
customer engaged in inventory reduction. Absent these two variables, we would have recorded growth for the year. We anticipate a return
to growth by the LLC and resumption of normal uptake by the food customer by Q2 2025. While there are many unknowns related to the new
administration, we feel that we are well positioned to grow in 2025 with the growth concentrated in second half.
Sales
for the year were flat compared with 2023; $38.23 MM vs $38.32 MM.
Profits:
2024 shows a profit of $3.04 million or 24 cents per share, compared to a profit of $2.78 million, or 22 cents per share, in 2023.
[Note that 2024 profit would have been 27 cents except for the temporary accounting loss on the sale of the FL LLC.]
Operating
Cash Flow: This non-GAAP number is useful to show our progress especially with non-cash items removed for clarity. For 2024, it was
$7.08 million or 57 cents per share up from $4.60 million or 37 cents per share in 2023.
Additional
factory space in Illinois: In the second quarter 2023 we invested to acquire 80% of an LLC called 317 Mendota that purchased a large
building on 37 acres of land in Mendota IL. We have determined that 240,000 square feet is available for our use or for rental. The ENP
division has moved all operations to 60,000 square feet of this building. A second tenant moved in during 2024. The remaining 130,000
square feet will be rented when suitable tenants are found.
Long-term
debt: We continue to pay down our long-term debt according to the terms of the loans. The loan we used to buy our ENP division is
paid in full in June this year. Our three-year note for equipment is fully paid in December 2025. This will free up over $2M in cash
flow per year for other purposes.
Working
capital is adequate for all our purposes. We have lines of credit with Stock Yards Bank for the ENP and NCS subsidiaries. We are
confident that we can execute our plans with our existing capital.
The
text of this speech will be available as an 8K filing on www.sec.gov by Thursday April 3rd. Email or fax copies can
be requested from Jason Bloom at Jason@flexiblesolutions.com. Thank you, the floor is open for questions.
Flexible
8-K Item 8.01 Yr End Financial Results & Speech 4-1-25
v3.25.1
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionISO 3166-1 alpha-2 country code.
+ References
+ Details
Name: |
dei_EntityAddressCountry |
Namespace Prefix: |
dei_ |
Data Type: |
dei:countryCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14a -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Flexible Solutions (AMEX:FSI)
과거 데이터 주식 차트
부터 3월(3) 2025 으로 4월(4) 2025
Flexible Solutions (AMEX:FSI)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 4월(4) 2025